Return-to-play decisions for athletes with sickle cell trait (SCT) often involve which of the following statements?

Return-to-play decisions for athletes with sickle cell trait (SCT) often involve which of the following statements?

• A. The athlete may RTP the same day or be disqualified from further participation.
• B. Athletes whose conditions are identified quickly and managed appropriately may return the same day as symptoms subside.
• C. Others have self-limiting myalgia from myonecrosis and may need 1 to 2 weeks of recovery with serial assessments.
• D. All of the above.

Answer: (D)

The idea behind return-to-play for athletes with sickle cell trait is that decisions are individualized based on how the athlete recovers from exertional symptoms. Some athletes may be cleared to resume activity the same day, or in rare cases may be disqualified from further participation, depending on the severity of their presentation and safety considerations. When symptoms are identified quickly and management is appropriate, clearance can occur the same day as the symptoms subside, highlighting the value of rapid assessment, hydration, cooling, and monitoring. Others may experience self-limiting muscle pain from injury or myonecrosis and require a short recovery period, typically 1 to 2 weeks, with serial assessments to track improvement and ensure safety before returning to play. Taken together, these scenarios reflect the range of RTP pathways that can apply to SCT athletes, which is why all of the above statements accurately describe possible decisions.

The idea behind return-to-play for athletes with sickle cell trait is that decisions are individualized based on how the athlete recovers from exertional symptoms. Some athletes may be cleared to resume activity the same day, or in rare cases may be disqualified from further participation, depending on the severity of their presentation and safety considerations. When symptoms are identified quickly and management is appropriate, clearance can occur the same day as the symptoms subside, highlighting the value of rapid assessment, hydration, cooling, and monitoring. Others may experience self-limiting muscle pain from injury or myonecrosis and require a short recovery period, typically 1 to 2 weeks, with serial assessments to track improvement and ensure safety before returning to play. Taken together, these scenarios reflect the range of RTP pathways that can apply to SCT athletes, which is why all of the above statements accurately describe possible decisions.